BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 27170059)

  • 1. Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults.
    Greenwood AM; Gunnarsson R; Neuen BL; Oliver K; Green SJ; Baer RA
    Nephrology (Carlton); 2017 Jul; 22(7):520-530. PubMed ID: 27170059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
    Bagchi S; Agarwal S; Kalaivani M; Bhowmik D; Singh G; Mahajan S; Dinda A
    Nephron; 2016; 132(2):81-5. PubMed ID: 26799973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.
    Laurin LP; Gasim AM; Derebail VK; McGregor JG; Kidd JM; Hogan SL; Poulton CJ; Detwiler RK; Jennette JC; Falk RJ; Nachman PH
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1752-1759. PubMed ID: 27445167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
    He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
    BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
    Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults.
    Jafry N; Ahmed E; Mubarak M; Kazi J; Akhter F
    Nephrol Dial Transplant; 2012 Mar; 27(3):1101-6. PubMed ID: 21804085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
    Troost JP; Trachtman H; Spino C; Kaskel FJ; Friedman A; Moxey-Mims MM; Fine RN; Gassman JJ; Kopp JB; Walsh L; Wang R; Gipson DS
    Am J Kidney Dis; 2021 Feb; 77(2):216-225. PubMed ID: 32791086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis.
    Alexopoulos E; Stangou M; Papagianni A; Pantzaki A; Papadimitriou M
    Nephrol Dial Transplant; 2000 Sep; 15(9):1348-56. PubMed ID: 10978390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathological and prognostic study of 18 children with C1q nephropathy and focal segmental glomerulosclerosis: an 18-year experience from a single center.
    Peng Y; Ju T; Gao C; Xia Z; Wang M; Sun X; Wang R; Li X; Wei Y; Jia L; Chen H
    J Nephrol; 2023 Jul; 36(6):1615-1625. PubMed ID: 37428438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of the Oxford classification of IgA nephropathy to predict renal survival.
    Alamartine E; Sauron C; Laurent B; Sury A; Seffert A; Mariat C
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2384-8. PubMed ID: 21885791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of collapsing focal segmental glomerulosclerosis.
    Raja R; Nada R; Yadav AK; Kumar A; Goyal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
    Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis.
    Troost JP; Trachtman H; Nachman PH; Kretzler M; Spino C; Komers R; Tuller S; Perumal K; Massengill SF; Kamil ES; Oh G; Selewski DT; Gipson P; Gipson DS
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):414-421. PubMed ID: 29167190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focal segmental glomerulosclerosis: prognosis of chronic renal failure].
    Razukeviciene L; Kuzminskis V; Bumblyte IA
    Medicina (Kaunas); 2003; 39 Suppl 1():16-22. PubMed ID: 12761415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.
    Hommos MS; Zeng C; Liu Z; Troost JP; Rosenberg AZ; Palmer M; Kremers WK; Cornell LD; Fervenza FC; Barisoni L; Rule AD
    Kidney Int; 2018 May; 93(5):1175-1182. PubMed ID: 29273332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.
    Wang CS; Gander J; Patzer RE; Greenbaum LA
    Am J Kidney Dis; 2018 Mar; 71(3):392-398. PubMed ID: 29277509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients.
    Kwon YE; Han SH; Kie JH; An SY; Kim YL; Park KS; Nam KH; Leem AY; Oh HJ; Park JT; Chang TI; Kang EW; Kang SW; Choi KH; Lim BJ; Jeong HJ; Yoo TH
    BMC Nephrol; 2014 Mar; 15():52. PubMed ID: 24666814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
    Troyanov S; Wall CA; Miller JA; Scholey JW; Cattran DC;
    J Am Soc Nephrol; 2005 Apr; 16(4):1061-8. PubMed ID: 15716334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
    Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
    Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.